Jump to content

Recommended Posts

Posted
5 hours ago, Spekulatius said:

Tariffs could become a big issue once the Eye of Sauron looks at Denmark and NVO.

 

Spek, please try to use "current administration" next time.  What you said can be deemed to be inflammatory or antagonistic, which only opens the thread to further political comments.  Cheers!

Posted
On 2/11/2025 at 11:26 AM, Cod Liver Oil said:

Added to Crox. All the shoe companies seem to be tariff casualties. I like Crox at 90 and NKE at 70. Skechers and Deck getting tarred with the same brush. Thank you, Orange Man!!! 

Cod, please try to use "President Trump!!!" next time.  What you said can be deemed to be inflammatory or antagonistic, which only opens the thread to further political comments. Cheers!

Posted
2 hours ago, Lazarus said:

Cod, please try to use "President Trump!!!" next time.  What you said can be deemed to be inflammatory or antagonistic, which only opens the thread to further political comments. Cheers!

 

Yup, you too Cod!  But he doesn't have to use "President Trump".  He can also just say "current administration." 

 

Cheers!

 

 

Posted (edited)
15 hours ago, Spekulatius said:

Tariffs could become a big issue once ... .... looks at Denmark and NVO.

 

CEO Lars Fruergaard Jørgensen was specifically asked about it in an interview a few days ago. [I think it must have been in connection with the release last week of the Annual Report for 2024, which I'm still digesting and chewing on.] Mr. Jørgensen said he considered it manageable for the company, because the company already has production and production capacity in the US. The answer was phrased in a way, that I perceived it as not just a triviality, though.

 

- - - o 0 o - - -

 

Edit :

 

Here is the interview

 

Bloomberg - Industries - Health [February 5th 2025] : Novo Sees Ozempic Boom Prompting Another Sales Surge.

Edited by John Hjorth
Posted
28 minutes ago, John Hjorth said:

 

Welcome in the arena ❗, @dipod 💡😎

 

image.png.6dee6455332c33eb0337ffeb145b9245.png

Its a very nice company and they have access to a great talent pool...i own a tracker now too and is a joy to follow what breakthroughs they will come up with in the future.

Posted

I picked up a few shares of ISSC and hope to add a little each day as I keep selling off some other stuff.  I got lucky a couple of days ago and picked up a few shares of POWW cumulative preferred when it dropped 10% for no reason (sloppy seller? fat finger?).  I had other limit orders in for it at different prices, but none got filled 😥

 

Adding a tiny bit of VG each day.  I'm glad I didn't go big all at once, but sometimes the opportunity passes quickly like Fairfax after the short report.  

Posted (edited)
On 2/14/2025 at 4:19 AM, John Hjorth said:

 

CEO Lars Fruergaard Jørgensen was specifically asked about it in an interview a few days ago. [I think it must have been in connection with the release last week of the Annual Report for 2024, which I'm still digesting and chewing on.] Mr. Jørgensen said he considered it manageable for the company, because the company already has production and production capacity in the US. The answer was phrased in a way, that I perceived it as not just a triviality, though.

 

- - - o 0 o - - -

 

Edit :

 

Here is the interview

 

Bloomberg - Industries - Health [February 5th 2025] : Novo Sees Ozempic Boom Prompting Another Sales Surge.

I checked on this, NVO revenue are 57.5% (167/290B DKK) in the US, but the US manufacturing site is only the 4th largest site of NVO, which to me indicates they are importing a lot into the US. This makes them vulnerable to tariffs. Trump has specifically mentioned medicine/drug imports a few times as well. Also, NVO is Danish and there is this Greenland thing going on as you well know.

 

I expect we will hear more about this. European tariffs are on the menu, I think by April 1st and I don’t  think it’s going to be a joke.

Edited by Spekulatius
Posted (edited)
On 12/21/2024 at 10:56 AM, Spekulatius said:

It’s basically a uniform laundry/ consumables business similar to VSTS or Cintas

 

How has Cintas have such an outstanding absolute and relative to peer track record?  Just heard about Cintas on Liberty's recent podcast and had to check out the company.

 

 

edit: a bit of it is - quality driven? -multiple expansion.

Edited by villainx
Posted
13 hours ago, villainx said:

 

How has Cintas have such an outstanding absolute and relative to peer track record?  Just heard about Cintas on Liberty's recent podcast and had to check out the company.

 

 

edit: a bit of it is - quality driven? -multiple expansion.

Definitely multiple expansion because they outperformed the competition for quite some time.

Posted
44 minutes ago, Spekulatius said:

Definitely multiple expansion because they outperformed the competition for quite some time.

 

On a personal note, I really feel like I'm living in a dream/simulation reality.  It's like, there are these supposedly great compounders out there, constellation software, waste management, transdigm, costco, etc., and then I listen to a podcast, and what the heck, there's another great compounder that isn't some new flash in the pan company, but - like Cintas - has actually been around for decades and decades.

 

Always something new or new to learn.  

Posted
On 2/4/2025 at 9:16 AM, Blake Hampton said:

Just bought a 3-year subscription to Value Line.

 

What happened to Blake Hampton?  Did he buy a value line subscription and disappear burying his nose into undervalued stock after undervalued stock?  Or has he disappeared from the forum entirely!?

 

Has the unsustainable government finance situation claimed another victim?!

Posted (edited)
3 hours ago, CorpRaider said:

I wonder if he got the sweet sweet paper version.  Jealous.

Library online subscription and a printer at work is the shit

Edited by Hsmpanl
Posted
28 minutes ago, Ross812 said:

increased my DFIN position by 25%


How large of a position is this for you now? 
 

Any concerns over deal volume? Mgmt has mentioned for a few Qs now (if memory serves) that they are optimistic that deal volume is turning…but doesn’t seem to materialize. 
 

Also, are you looking at comps? Have they seen similar volume declines? I notice WK stock is also down from its highs…

Posted
1 hour ago, LC said:


How large of a position is this for you now? 
 

Any concerns over deal volume? Mgmt has mentioned for a few Qs now (if memory serves) that they are optimistic that deal volume is turning…but doesn’t seem to materialize. 
 

Also, are you looking at comps? Have they seen similar volume declines? I notice WK stock is also down from its highs…

 

Its about 6% still. It was down 20% today and I added 25% so no real change.

 

The financial service revenue tied to mergers and IPOs is cyclical and I agree management has been rosy with projecting a turn for at least 18 months now. The stock was hammered for guiding 4% lower YOY revenues compared to Q1'24 and missed revenue by 10M in Q4 based on mergers and IPOs coming in lower than expected. WK and the whole sector listed company financial services is down. I pay attention to the SaaS compliance software making up 42% of revenue which is durable and growing at 11-13% YoY. In the long run, print is going to run-off to 0 and you are going to have a boring SaaS company serving a large percentage of publicly listed companies with a cyclical one off financial services support to mergers and IPOs giving a kicker when activity ticks up. My fear is the cutting of regulations impacts the SaaS side. So far, this doesn't look like its an issue, so I'm holding my nose and averaging up. 

 

 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...